To enable the translation of gene-corrected AM therapy to PAP patients, a self-inactivating (SIN) lentiviral vector expressing a codon-optimized human CSF2RA-cDNA driven by an EF1α short promoter (Lv.EFS.CSF2RAcoop) was created. This evidence concerns the gene CSF2RA and pulmonary alveolar proteinosis.